The stock of Equillium Inc (EQ) has gone down by -1.77% for the week, with a 13.08% rise in the past month and a -37.50% drop in the past quarter. The volatility ratio for the week is 18.07%, and the volatility levels for the past 30 days are 12.24% for EQ. The simple moving average for the last 20 days is -1.88% for EQ’s stock, with a simple moving average of -29.11% for the last 200 days.
Is It Worth Investing in Equillium Inc (NASDAQ: EQ) Right Now?
EQ has 36-month beta value of 1.77. Analysts have mixed views on the stock, with 2 analysts rating it as a “buy,” 1 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for EQ is 17.41M, and currently, short sellers hold a 0.60% ratio of that float. The average trading volume of EQ on January 24, 2025 was 196.86K shares.
EQ) stock’s latest price update
The stock price of Equillium Inc (NASDAQ: EQ) has jumped by 3.26 compared to previous close of 0.67. Despite this, the company has seen a fall of -1.77% in its stock price over the last five trading days. businesswire.com reported 2024-11-13 that LA JOLLA, Calif.–(BUSINESS WIRE)—- $EQ–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced financial results for the third quarter 2024 and provided corporate and clinical updates. “At the end of October we announced that our partnership with Ono Pharmaceutical had ended following substantial non-dilutive financing that has fully fund.
Analysts’ Opinion of EQ
Many brokerage firms have already submitted their reports for EQ stocks, with Stifel repeating the rating for EQ by listing it as a “Buy.” The predicted price for EQ in the upcoming period, according to Stifel is $12 based on the research report published on October 29, 2021 of the previous year 2021.
Cantor Fitzgerald, on the other hand, stated in their research note that they expect to see EQ reach a price target of $14. The rating they have provided for EQ stocks is “Overweight” according to the report published on September 15th, 2021.
H.C. Wainwright gave a rating of “Buy” to EQ, setting the target price at $24 in the report published on July 14th of the previous year.
EQ Trading at -2.33% from the 50-Day Moving Average
After a stumble in the market that brought EQ to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.85% of loss for the given period.
Volatility was left at 12.24%, however, over the last 30 days, the volatility rate increased by 18.07%, as shares surge +13.98% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -10.61% lower at present.
During the last 5 trading sessions, EQ fell by -2.61%, which changed the moving average for the period of 200-days by -64.50% in comparison to the 20-day moving average, which settled at $0.7004. In addition, Equillium Inc saw -8.11% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EQ starting from Keyes Jason A, who sale 10,000 shares at the price of $0.70 back on Nov 14 ’24. After this action, Keyes Jason A now owns 47,720 shares of Equillium Inc, valued at $7,000 using the latest closing price.
THE KEYES TRUST U/A DTD 09/10/, the Officer of Equillium Inc, proposed sale 20,000 shares at $0.78 during a trade that took place back on Nov 14 ’24, which means that THE KEYES TRUST U/A DTD 09/10/ is holding shares at $15,608 based on the most recent closing price.
Stock Fundamentals for EQ
Current profitability levels for the company are sitting at:
- -0.15 for the present operating margin
- 1.0 for the gross margin
The net margin for Equillium Inc stands at -0.1. The total capital return value is set at -0.29. Equity return is now at value -19.52, with -10.29 for asset returns.
Based on Equillium Inc (EQ), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -43.04.
Currently, EBITDA for the company is -12.14 million with net debt to EBITDA at 2.89. When we switch over and look at the enterprise to sales, we see a ratio of 0.2. The receivables turnover for the company is 9.17for trailing twelve months and the total asset turnover is 1.33. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.04.
Conclusion
To put it simply, Equillium Inc (EQ) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
